| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 27.08. | KDA Group Inc: KDA Group appoints Potvin director | 2 | Stockwatch | ||
| 26.08. | Kda Group Appoints Louise Potvin To Its Board Of Directors | 1 | CNW | ||
| 02.06. | KDA Group Inc: KDA Group 250,000 shares for debt | 1 | Stockwatch | ||
| 30.05. | KDA Group Inc: KDA Group issues 250,000 shares for debt of $25,000 | 1 | Stockwatch | ||
| 30.05. | Kda Group Completes Debt Settlement | 1 | CNW | ||
| 05.05. | Kda Group Announces Results Of Shareholders' Annual General Meeting And The Settlement Of Judicial Claims | 1 | CNW | ||
| KDA GROUP Aktie jetzt für 0€ handeln | |||||
| 10.04. | KDA Group Inc: KDA appoints Kirouac as chief technology officer of GTK | 1 | Stockwatch | ||
| 09.04. | Kda Group Announces The Appointment Of Martin Kirouac As Chief Technology Officer Of Its Subsidiary Groupe Technologique Kda | 1 | CNW |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS MEDICAL CARE | 40,270 | -0,33 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 30,680 | +0,32 % | Carl Zeiss Meditec: Das Chartbild sieht spannend aus, aber … | Nachdem Carl Zeiss Meditec im Januar eine Gewinnwarnung veröffentlichte und einbrach, gelang zwar eine Bodenbildung, aber zurück in den Fokus der Käufer gelangte die Aktie nicht mehr. Doch jetzt sieht... ► Artikel lesen | |
| UNITEDHEALTH | 332,80 | +0,73 % | UnitedHealthcare Unveils FY27 Medicare Advantage Plans | MINNETONKA (dpa-AFX) - Health care and well-being major UnitedHealth Group Inc. (UNH) Thursday introduced its 2027 Medicare Advantage plans, focused on affordability, simplicity and a more connected... ► Artikel lesen | |
| HIMS & HERS HEALTH | 25,960 | +0,78 % | Hims & Hers Names Chief Medical Officers in the UK and Australia, Deepening its Investment in Local Clinical Leadership | Kultar Garcha, MD, joins as Chief Medical Officer of the UK and EMEA, and Matt Vickers, FRACGP, MBBS, BMedSci, AICGG, is named Chief Medical Officer of Hims Australia, guiding clinical strategy... ► Artikel lesen | |
| BICO GROUP | 1,944 | -2,02 % | BICO Group AB: BICO Completes Integration of Cellenion into SCIENION, Strengthening Precision Biotech Platform | BICO Group AB (publ) today announces the completion of the integration of Cellenion into SCIENION, bringing the businesses, technologies, and teams together under a single organization and brand.
This... ► Artikel lesen | |
| NUGEN MEDICAL DEVICES | 0,011 | -100,00 % | NuGen Medical Devices Inc.: NuGen Announces Loan Agreement with Sol-Millennium Medical HK Limited | Toronto, Ontario--(Newsfile Corp. - September 21, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen" or the "Company") is pleased to announce the entering into of a loan agreement (the "Loan Agreement")... ► Artikel lesen | |
| UNIDOC HEALTH | 0,050 | -5,97 % | XFRA L7T: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILUNIDOC HEALTH CORP.... ► Artikel lesen | |
| VERU | 2,525 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 02.10.2026 -5- | The following instruments on Boerse Frankfurt do have their last trading day on 02.10.2026Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 02.10.2026ISIN NameUS75973T2006 RENALYTIX... ► Artikel lesen | |
| VIROMED MEDICAL | 5,750 | -1,69 % | EQS-News: Viromed Medical AG treibt Produktentwicklung und Markteinführung im ersten Halbjahr 2026 voran und bestätigt Prognose für das Gesamtjahr | EQS-News: Viromed Medical AG
/ Schlagwort(e): Halbjahresbericht
Viromed Medical AG treibt Produktentwicklung und Markteinführung im ersten Halbjahr 2026 voran und bestätigt Prognose... ► Artikel lesen | |
| CLARIANE | 3,236 | 0,00 % | Clariane: Signing of a new €700 million syndicated revolving credit facility maturing 2031 | 21 September 2026 Signing of a new €700 million revolving credit facility maturing in 2031 Paris, 21 September 2026: following the success of its €500 million senior bonds offering completed on 8 September... ► Artikel lesen | |
| BONESUPPORT | 20,800 | +5,21 % | Bonesupport Holding AB: BONESUPPORT HOLDING AB (publ) - publishes Q2 2026 interim report | BONESUPPORT HOLDING AB (publ), a leading company in orthobiologics for the management of bone injuries, today publishes the interim report for the second quarter 2026.
"Strong growth and improved operating... ► Artikel lesen | |
| SENSEONICS | 8,700 | -1,14 % | TD Cowen bestätigt Kaufempfehlung für Senseonics Aktie aufgrund von Wachstumstreibern | ||
| GLOBAL HEMP GROUP | 0,014 | -100,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 02.10.2026 -1- | The following instruments on Boerse Frankfurt do have their last trading day on 02.10.2026Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 02.10.2026ISIN NameAGP8696W1045 SINOVAC... ► Artikel lesen | |
| BEYOND AIR | 2,850 | 0,00 % | Beyond Air Receives FDA Breakthrough Device Designation for LungFit GO to Treat Nontuberculous Mycobacterial Pulmonary Disease (NTM-PD) | GARDEN CITY, N.Y., Aug. 31, 2026 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) ("Beyond Air" or the "Company"), a commercial-stage medical device and biopharmaceutical company focused on harnessing... ► Artikel lesen | |
| M3 INC | 10,135 | +0,85 % | M3, Inc. Profit Declines In Q1 | TOKYO (dpa-AFX) - M3, Inc. (4YC.F) revealed earnings for first quarter that Dropped, from last yearThe company's earnings totaled JPY9.074 billion, or JPY13.59 per share. This compares with... ► Artikel lesen |